コンテンツへスキップ
Merck
  • EGFR-mediated epidermal stem cell motility drives skin regeneration through COL17A1 proteolysis.

EGFR-mediated epidermal stem cell motility drives skin regeneration through COL17A1 proteolysis.

The Journal of cell biology (2021-09-23)
Daisuke Nanba, Fujio Toki, Kyosuke Asakawa, Hiroyuki Matsumura, Ken Shiraishi, Koji Sayama, Kyoichi Matsuzaki, Hiroshi Toki, Emi K Nishimura
要旨

Skin regenerative capacity declines with age, but the underlying mechanisms are largely unknown. Here we demonstrate a functional link between epidermal growth factor receptor (EGFR) signaling and type XVII collagen (COL17A1) proteolysis on age-associated alteration of keratinocyte stem cell dynamics in skin regeneration. Live-imaging and computer simulation experiments predicted that human keratinocyte stem cell motility is coupled with self-renewal and epidermal regeneration. Receptor tyrosine kinase array identified the age-associated decline of EGFR signaling in mouse skin wound healing. Culture experiments proved that EGFR activation drives human keratinocyte stem cell motility with increase of COL17A1 by inhibiting its proteolysis through the secretion of tissue inhibitor of metalloproteinases 1 (TIMP1). Intriguingly, COL17A1 directly regulated keratinocyte stem cell motility and collective cell migration by coordinating actin and keratin filament networks. We conclude that EGFR-COL17A1 axis-mediated keratinocyte stem cell motility drives epidermal regeneration, which provides a novel therapeutic approach for age-associated impaired skin regeneration.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
抗α-チューブリン抗体, マウスモノクローナル, clone DM1A, purified from hybridoma cell culture
Sigma-Aldrich
GenElute 哺乳動物用total RNAミニプレップキット, sufficient for 70 purifications
Sigma-Aldrich
マリマスタット, ≥98% (HPLC)
Sigma-Aldrich
Anti-phospho-EGFR (Tyr845) Antibody, Upstate®, from rabbit